Allstate (NYSE:ALL) PT Raised to $214.00

Allstate (NYSE:ALLFree Report) had its price target boosted by BMO Capital Markets from $205.00 to $214.00 in a research note published on Friday, Marketbeat Ratings reports. The firm currently has an outperform rating on the insurance provider’s stock.

A number of other analysts have also recently commented on ALL. StockNews.com cut Allstate from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 21st. Bank of America cut their target price on Allstate from $226.00 to $216.00 and set a “buy” rating for the company in a research report on Thursday, October 10th. Morgan Stanley cut their target price on Allstate from $205.00 to $200.00 and set an “overweight” rating for the company in a research report on Wednesday, July 10th. TD Cowen increased their target price on Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd. Finally, The Goldman Sachs Group increased their target price on Allstate from $199.00 to $204.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $206.44.

Check Out Our Latest Analysis on Allstate

Allstate Stock Performance

Shares of ALL opened at $192.64 on Friday. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.49. The business has a 50-day simple moving average of $187.08 and a two-hundred day simple moving average of $173.96. The stock has a market cap of $50.84 billion, a price-to-earnings ratio of 42.53, a PEG ratio of 1.74 and a beta of 0.48. Allstate has a 52 week low of $121.70 and a 52 week high of $198.79.

Allstate (NYSE:ALLGet Free Report) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $1.28. The business had revenue of $15.71 billion during the quarter, compared to analysts’ expectations of $14.04 billion. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The business’s quarterly revenue was up 12.4% on a year-over-year basis. During the same quarter in the prior year, the business posted ($4.42) earnings per share. On average, analysts expect that Allstate will post 15.19 EPS for the current year.

Insider Activity at Allstate

In other Allstate news, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at $15,880,915.68. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 192,530 shares of company stock worth $34,967,665 in the last quarter. 1.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the stock. Rise Advisors LLC purchased a new position in Allstate during the 1st quarter worth $26,000. Northwest Investment Counselors LLC purchased a new position in Allstate during the 1st quarter worth $26,000. Versant Capital Management Inc grew its stake in Allstate by 70.9% during the 2nd quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after buying an additional 78 shares during the last quarter. Family Firm Inc. purchased a new position in Allstate during the 2nd quarter worth $38,000. Finally, MCF Advisors LLC grew its stake in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after purchasing an additional 84 shares during the last quarter. 76.47% of the stock is owned by institutional investors.

Allstate Company Profile

(Get Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Read More

Analyst Recommendations for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.